EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Mar 30, 2024 | Option Exercise | $20.67 | 25,546 | 528,036 | 77,133 | Apr 02, 2024, 05:27 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2024 | Option Exercise | $28.80 | 5,083 | 146,390 | 44,787 | Feb 13, 2024, 05:39 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 26, 2024 | Option Exercise | $13.06 | 49,325 | 644,047 | 85,830 | Jan 30, 2024, 04:53 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 26, 2024 | Sale | $25.66 | 49,325 | 1,265,539 | 85,779 | Jan 30, 2024, 04:53 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 25, 2024 | Option Exercise | $13.01 | 600 | 7,809 | 37,105 | Jan 29, 2024, 05:51 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 25, 2024 | Sale | $25.00 | 600 | 15,000 | 36,805 | Jan 29, 2024, 05:51 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 23, 2024 | Option Exercise | $13.04 | 5,135 | 66,954 | 41,640 | Jan 25, 2024, 06:26 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 23, 2024 | Sale | $25.00 | 5,135 | 128,375 | 39,601 | Jan 25, 2024, 06:26 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 24, 2024 | Option Exercise | $13.01 | 11,251 | 146,426 | 47,756 | Jan 25, 2024, 06:26 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 24, 2024 | Sale | $25.01 | 11,251 | 281,415 | 42,156 | Jan 25, 2024, 06:26 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 08, 2024 | Option Exercise | $3.26 | 22,913 | 74,696 | 59,418 | Jan 10, 2024, 04:53 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 08, 2024 | Sale | $21.13 | 22,913 | 484,124 | 36,505 | Jan 10, 2024, 04:53 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,487 | 91,535 | 36,505 | Jan 09, 2024, 09:28 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Dec 13, 2023 | Option Exercise | $10.13 | 1,458 | 14,770 | 27,165 | Dec 15, 2023, 05:14 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Dec 13, 2023 | Sale | $20.00 | 1,458 | 29,160 | 25,707 | Dec 15, 2023, 05:14 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Dec 04, 2023 | Option Exercise | $10.13 | 30,625 | 310,231 | 56,332 | Dec 06, 2023, 05:19 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Dec 04, 2023 | Sale | $22.00 | 30,625 | 673,750 | 25,707 | Dec 06, 2023, 05:19 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2023 | Option Exercise | $4.17 | 3,744 | 15,612 | 27,429 | Feb 13, 2023, 05:07 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,294 | 12,875 | 18,651 | Mar 02, 2022, 06:21 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,721 | 17,434 | 15,840 | Feb 11, 2022, 04:39 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,423 | 15,383 | 11,592 | Mar 02, 2021, 07:26 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 30, 2020 | Option Exercise | $0.76 | 12,049 | 9,121 | 89,144 | Jul 02, 2020, 06:14 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2020 | Option Exercise | $0.79 | 2,936 | 2,317 | 60,143 | Jun 30, 2020, 07:52 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2020 | Option Exercise | $0.83 | 4,168 | 3,441 | 53,079 | Jun 16, 2020, 05:00 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2019 | Option Exercise | $2.11 | 2,450 | 5,157 | 43,047 | Oct 15, 2019, 06:03 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2019 | Option Exercise | $1.65 | 2,940 | 4,851 | 45,497 | Jun 28, 2019, 05:04 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2019 | Option Exercise | $1.53 | 4,175 | 6,388 | 38,437 | Jun 17, 2019, 05:40 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Mar 19, 2019 | Option Exercise | $2.47 | 1,188 | 2,934 | 28,412 | Mar 21, 2019, 05:24 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2018 | Option Exercise | $3.23 | 2,455 | 7,930 | 29,600 | Oct 16, 2018, 04:00 PM |
EYPT | | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2018 | Option Exercise | $1.86 | 2,945 | 5,478 | 15,388 | Jun 29, 2018, 04:00 PM |